Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished Apr 22, 2026 1:00 PM ・ Updated Jun 2, 2026 1:02 PM ・ 2 min read ・ Source: PR TIMES
Pharmaceutical venture SENTAN Pharma has reported positive results in its basic research on γ-oryzanol, an ingredient derived from brown rice. This demonstrates the effectiveness of the company's proprietary particle technology and holds promise for future product development.
SENTAN Pharma is a venture company that provides technology to enhance the effectiveness of products by applying its proprietary nano-particle and micro-particle technologies to the manufacturing processes of pharmaceuticals and health foods.
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.